Podcasters Roundtable: Melissa Berry on Fashion Meets Cancer Advocacy
Melissa Berry, founder of Cancer Fashionista and host of "Dear Cancer, I'm Beautiful," joins us to discuss building beauty and wellness resources for cancer patients. From her background as a fashion publicist to creating an evergreen podcast library, Melissa shares why looking like yourself matters, how she selects topics, and what keeps her connected to advocacy. We explore inclusive language for metastatic patients, financial toxicity, intimacy after cancer, and the power of podcasting as a tool for community building.
Front Row: SABCS 2025 Insights with Dr. Francisco Esteva
Join host Victoria Goldberg and Dr. Francisco Esteva as they break down the groundbreaking research from the San Antonio Breast Cancer Symposium 2025. Discover the latest advances in metastatic breast cancer treatment, including new first-line therapies for HER2-positive disease with 40-month progression-free survival, oral SERDs revolutionizing hormone receptor-positive treatment, and antibody drug conjugates transforming triple-negative breast cancer care. Dr. Esteva shares expert insights on brain metastasis prevention, liquid biopsy-guided therapy switching, and how artificial intelligence is reshaping oncology. Whether you're a patient, caregiver, or healthcare professional, this episode offers hope and practical information about the cutting-edge treatments available in 2026.
Future at Risk: What Happens when Funding Stops
In the world where breakthrough cancer treatments hang in the balance, federal funding cuts are threatening to derail critical research that could save countless lives.
Our guest is Dr. Gloria Echeverria, a molecular biologist and passionate advocate for scientific discovery, who leads her own lab at Baylor College of Medicine. Her team investigates the molecular and genetic mechanisms that make TNBC resistant to standard treatments like chemotherapy and radiation.She shares what it’s like to run a research lab in today’s climate, the challenges of securing funding, and the ripple effects these cuts have on training the next generation of scientists, advancing new therapies, and supporting patient advocates.